Inspire Medical Systems
INSP
288 hedge funds and large institutions have $5.94B invested in Inspire Medical Systems in 2021 Q4 according to their latest regulatory filings, with 53 funds opening new positions, 90 increasing their positions, 95 reducing their positions, and 15 closing their positions.
253% more first-time investments, than exits
New positions opened: 53 | Existing positions closed: 15
31% more call options, than puts
Call options by funds: $61.5M | Put options by funds: $46.8M
14% more funds holding
Funds holding: 252 → 288 (+36)
1.39% more ownership
Funds ownership: 93.1% → 94.49% (+1.4%)
1% more capital invested
Capital invested by funds: $5.91B → $5.94B (+$31.8M)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
5% less repeat investments, than reductions
Existing positions increased: 90 | Existing positions reduced: 95
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
+$62.7M |
| 2 |
Point72 Asset Management
Stamford,
Connecticut
|
+$47.7M |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$43.9M |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
+$35.3M |
| 5 |
TCM
TimesSquare Capital Management
New York
|
+$22.6M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$41.9M |
| 2 |
FCM
Frontier Capital Management
Boston,
Massachusetts
|
-$35.2M |
| 3 |
FAM
Fred Alger Management
New York
|
-$30.2M |
| 4 |
Wells Fargo
San Francisco,
California
|
-$27.5M |
| 5 |
Morgan Stanley
New York
|
-$26.3M |
INSP Hedge Fund Activity: Q4 2021 in Review
288 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Inspire Medical Systems (INSP) for Q4 2021, worth a combined $5.94B — up 0.54% from $5.91B a quarter earlier.
Buyers outnumbered sellers: 53 funds opened new INSP positions and 15 closed out — a net gain of 38 holders — while 90 added to existing stakes and 95 trimmed.
The largest buyer was Macquarie Group, adding an estimated $62.7M. The largest seller was Fidelity Investments, cutting an estimated $41.9M.
- 288 institutional investors held Inspire Medical Systems (INSP) as of Q4 2021, up from 252 in Q3 2021.
- Funds reported $5.94B of Inspire Medical Systems stock for Q4 2021, up 0.54% quarter-over-quarter.
- 53 funds opened new Inspire Medical Systems positions in Q4 2021 and 15 closed out, a net change of +38 holders.
- The largest Inspire Medical Systems buyer in Q4 2021 was Macquarie Group, an estimated $62.7M added.
- The largest Inspire Medical Systems seller in Q4 2021 was Fidelity Investments, an estimated $41.9M sold.
Based on aggregated 13F filings for Q4 2021.